BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 36387201)

  • 1. One size does not fit all: Evaluating disparities in lung cancer screening eligibility amongst the Hispanic population.
    Olazagasti C; Ehrlich M; Seetharamu N
    Front Oncol; 2022; 12():995408. PubMed ID: 36387201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missed Opportunities? An Observational Analysis of Lung Cancer Screening Utilization Amongst Patients With Lung Cancer.
    Olazagasti C; Ehrlich M; Kohn N; Aviles K; Hoilett A; Seetharamu N
    Cancer Control; 2022; 29():10732748221077959. PubMed ID: 35157547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addressing Sex Disparities in Lung Cancer Screening Eligibility: USPSTF vs PLCOm2012 Criteria.
    Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Guzman A; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE
    Chest; 2022 Jan; 161(1):248-256. PubMed ID: 34252436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Prediction Models to Reduce Persistent Racial and Ethnic Disparities in the Draft 2020 USPSTF Lung Cancer Screening Guidelines.
    Landy R; Young CD; Skarzynski M; Cheung LC; Berg CD; Rivera MP; Robbins HA; Chaturvedi AK; Katki HA
    J Natl Cancer Inst; 2021 Nov; 113(11):1590-1594. PubMed ID: 33399825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung Cancer Screening in Brazil Comparing the 2013 and 2021 USPSTF Guidelines.
    Emmerick ICM; Campos MR; Castanheira D; Muzy J; Marques A; Arueira Chaves L; Sobreira da Silva MJ
    JAMA Netw Open; 2023 Dec; 6(12):e2346994. PubMed ID: 38079172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Disparities by Sex and Race or Ethnicity in Lung Cancer Screening Eligibility Rates.
    Pinsky PF; Lau YK; Doubeni CA
    Chest; 2021 Jul; 160(1):341-350. PubMed ID: 33545164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling Strategies to Optimize Cancer Screening in USPSTF Guideline-Noncompliant Women.
    Taksler GB; Peterse EFP; Willems I; Ten Haaf K; Jansen EEL; de Kok IMCM; van Ravesteyn NT; de Koning HJ; Lansdorp-Vogelaar I
    JAMA Oncol; 2021 Jun; 7(6):885-894. PubMed ID: 33914025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Prediction Model Versus United States Preventive Services Task Force Lung Cancer Screening Eligibility Criteria: Reducing Race Disparities.
    Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE
    J Thorac Oncol; 2020 Nov; 15(11):1738-1747. PubMed ID: 32822843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing how lung cancer screening guidelines contribute to racial disparities in screening access.
    Ivic-Pavlicic T; Joshi S; Zegarelli A; Taioli E
    Transl Lung Cancer Res; 2023 May; 12(5):1122-1132. PubMed ID: 37323180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung Cancer Screening Criteria and Cardiopulmonary Comorbidities.
    Pu CY; Lusk CM; Neslund-Dudas C; Gadgeel S; Soubani AO; Schwartz AG
    JTO Clin Res Rep; 2022 Aug; 3(8):100377. PubMed ID: 35880085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Black Race Remains Associated with Lower Eligibility for Screening Using 2021 US Preventive Services Task Force Recommendations Among Lung Cancer Patients at an Urban Safety Net Hospital.
    Liu A; Siddiqi N; Tapan U; Mak KS; Steiling KA; Suzuki K
    J Racial Ethn Health Disparities; 2023 Dec; 10(6):2836-2843. PubMed ID: 36441493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Eligibility for Lung Cancer Screening by Race After 2021 Changes to US Preventive Services Task Force Screening Guidelines.
    Pinheiro LC; Groner L; Soroka O; Prosper AE; Jack K; Tamimi RM; Safford M; Phillips E
    JAMA Netw Open; 2022 Sep; 5(9):e2229741. PubMed ID: 36053535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial and Ethnic Disparities in Lung Cancer Screening Eligibility.
    Narayan AK; Chowdhry DN; Fintelmann FJ; Little BP; Shepard JO; Flores EJ
    Radiology; 2021 Dec; 301(3):712-720. PubMed ID: 34546133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care Systems.
    Ritzwoller DP; Meza R; Carroll NM; Blum-Barnett E; Burnett-Hartman AN; Greenlee RT; Honda SA; Neslund-Dudas C; Rendle KA; Vachani A
    JAMA Netw Open; 2021 Oct; 4(10):e2128176. PubMed ID: 34636916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of Risk Factor-Based Guidelines and Model-Based Chest CT Lung Cancer Screening in World Trade Center-Exposed Fire Department Rescue/Recovery Workers.
    Cleven KL; Vaeth B; Zeig-Owens R; Colbeth HL; Jaber N; Schwartz T; Weiden MD; Markowitz SB; Silvestri GA; Prezant DJ
    Chest; 2021 May; 159(5):2060-2071. PubMed ID: 33279511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Race & sex disparities related to low-dose computed tomography lung cancer screening eligibility criteria: A lung cancer cases review.
    Williams RM; Kareff SA; Sackstein P; Roy T; Luta G; Kim C; Taylor KL; Tammemägi MC
    Lung Cancer; 2022 Jul; 169():55-60. PubMed ID: 35644087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of USPSTF Lung Cancer Screening Guidelines Among African American Adult Smokers.
    Aldrich MC; Mercaldo SF; Sandler KL; Blot WJ; Grogan EL; Blume JD
    JAMA Oncol; 2019 Sep; 5(9):1318-1324. PubMed ID: 31246249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparity Implications of Proposed 2015 Medicare Eligibility Criteria for Medication Therapy Management Services.
    Wang J; Qiao Y; Spivey CA; Li C; Clark C; Deng Y; Liu F; Tillman J; Chisholm-Burns M
    J Pharm Health Serv Res; 2016 Dec; 7(4):209-215. PubMed ID: 28025599
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.